Motus GI Announces Pricing of $20 Million Public Offering of Common Stock

Read Release

Motus GI Announces Proposed Public Offering of Common Stock

Read Release

Motus GI Bolsters Commercial and Quality/Regulatory Expertise with Two Key Senior Management Additions

Read Release

Motus GI to Present at the JMP Securities Life Sciences Conference

Read Release

Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2

Read Release

Motus GI Presents Positive Clinical Results from REDUCE Study Evaluating Pure-Vu® System in Hospitalized Colonoscopy Patients at Digestive Disease Week® 2019

Read Release

Motus GI to Present at the 20th Annual B. Riley FBR Investor Conference

Read Release

Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update

Read Release

Motus GI to Present Clinical Results from REDUCE Study Evaluating the Pure-Vu® System at Digestive Disease Week® 2019

Read Release